The vector of anti-MART1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MART1. The T cells are genetically modified through transduction with a lentiviral vector expressing MART1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C303||Lenti-melan-A T cell receptor (SW-M1-67) Viral Particle|
|CAR-WFY5531||Anti-MLANA (CBFYM-2272) h(CD28-CD3ζ) CAR, pCDCAR1|
|VP-TCR-C305||Lenti-MART-1 T cell receptor (Cysteine-modiﬁed) Viral Particle|
|CAR-T-1-M310-G||Anti-MART-1(DMF5) scFv h(FcεRIγ) CART, pCDCAR1|
|TCR-C137Z||Human anti-MART1 T cell receptor (F5), pCDTCR1|
|CAR-WFY2267||Anti-MLANA (CBFYM-0266) h(41BB-CD3ζ) CAR, pCDCAR1|
|DMAb-2279-FY||Mouse Anti-MLANA DNA-encoded mAb (CBFYM-2273), pVAX1|
|CAR-T-1-M310-Z||Anti-MART-1(DMF5) scFv h(CD3ζ) CART, pCDCAR1|
|TCR-L067Z||Murinized anti-MART-1 (ELAGIGILTV) T cell receptor (Cysteine-modiﬁed), pCDTCR1|
|VP-CAR-LC329||Lenti-MART-1(DMF5) CAR (scFv-CD28, Melan-A) Viral Particle|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved